Drug Topics staff

Here's a roundup of the latest coronavirus-related news. 

Armand Balboni, MD, PhD, chief executive officer of Appili Therapeutics, discusses the potential for favipiravir, an antiviral medication, for treating COVID-19 in certain populations.

Here's a roundup of the latest coronavirus-related news.

Julie Ann Justo, PharmD, infectious diseases clinical pharmacist and assistant professor at the University of South Carolina College of Pharmacy, discusses the treatment potential for remdesivir for SARS-CoV-2, as well as distribution strategies for the drug.

Carla Cox, PhD, registered dietician and certified diabetes educator, discusses key information about COVID-19 that individuals with diabetes should know.

Here's this week's roundup of the latest coronavirus-related news.

In an interview with Drug Topics®, Richard Scholz, chief strategy officer of ERxDirect, explained the prominence of telemedicine during the COVID-19 pandemic and the lasting implications of new technologies during unprecedented times.

Here's a roundup of the latest coronavirus-related news.

In part 2 of our interview, Mike Johnston, founder and chief executive officer of the National Pharmacy Technician Association (NPTA), discussed the results of their recent survey, which found that many pharmacists and pharmacy technicians feel unsafe from COVID-19 at their workplaces.

Mike Johnston, founder and chief executive officer of the National Pharmacy Technician Association (NPTA), joined Drug Topics® to discuss their recent survey that pinpointed where pharmacists are feeling most unprotected during the pandemic.

In part 2 of our interview, Devin English, assistant professor at Rutgers School of Health, joined Drug Topics® to discuss how COVID-19 is disproportionately affecting minorities.

Here's a roundup of the latest coronavirus-related news.

Here's a roundup of the latest coronavirus-related news.

Devin English, assistant professor at Rutgers School of Health, joined Drug Topics® to discuss how COVID-19 is disproportionately affecting minorities, the history that explains this trend, and the issues that will remain after the pandemic ends.

Here's a roundup of this week's coronavirus-related news.

Aman Brar, chief executive officer of Jobvite, discussed with Drug Topics® how recruiting software is transforming the hiring process during the coronavirus disease 2019 pandemic.

In part 2 of our video interview, Doug Hackenyos, oncology pharmacy clinical coordinator at the University of Connecticut, discusses the effects of COVID-19 on cancer care pharmacy.

In a video interview with Drug Topics®, Doug Hackenyos, oncology pharmacy clinical coordinator at the University of Connecticut, discusses the effects of COVID-19 on cancer care pharmacy. 

In part 2 of our video interview, Robert Brunault, PharmD, a clinical pharmacy specialist in hematology and oncology at Rhode Island Hospital and the Lifespan Cancer Institute, discussed drug shortages, FDA emergency use authorizations, and the biggest concerns for pharmacists.

In a video interview with Drug Topics®, Robert Brunault, PharmD, a clinical pharmacy specialist of hematology and oncology at Rhode Island Hospital and Lifespan Cancer Institute, answers questions about how the COVID-19 pandemic affects patients undergoing treatment for cancer.

Our most-read FDA approval articles from 2019. 

Q&A from ThoughtSpot 2019.

It's time for a little civic pride! Did your city make the list?

Legacy Pharma Expands NMBA Recall Notice

Researchers targeting virus' receptors used to enter the body. 

Updated recommendations for the diagnosis, treatment, prevention, and outbreak management of seasonal influenza. 

CDC reports seasonal influenza activity remains elevated and widespread throughout U.S.

Proposed HHS regulation would pass rebates on to consumers